Loading clinical trials...
Loading clinical trials...
Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis - A Prospective Clinical Trial
Conditions
Interventions
Elagolix 200 MG
Placebo or SOC IVF
Locations
5
United States
University of Colorado Department of Obstetrics & Gynecology
Aurora, Colorado, United States
Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences
New Haven, Connecticut, United States
Northwestern University Department of Obstetrics and Gynecology
Chicago, Illinois, United States
Johns Hopkins, Division of Reproductive Science and Women's Health Research
Baltimore, Maryland, United States
Duke Fertility
Morrisville, North Carolina, United States
Start Date
March 16, 2024
Primary Completion Date
June 30, 2026
Completion Date
September 30, 2026
Last Updated
July 24, 2025
NCT06826365
NCT07153367
NCT04872660
NCT07462065
NCT05903859
NCT06742437
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions